Literature DB >> 10928477

Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center.

T L Ortel1, A H James, E H Thames, K D Moore, C S Greenberg.   

Abstract

We evaluated the utility of the PFA-100 platelet function analyzer in identifying disorders in platelet function and/or von Willebrand factor (vWF) in patients with various systemic disorders being followed at a tertiary care center. Closure times were determined with collagen/ ADP (CADP) and collagen/epinephrine (CEPI) cartridges for 305 patients, and abnormal results were further evaluated with platelet aggregometry and vWF analysis. Prolonged CADP and/or CEPI closure times were identified in 114 patients (37.3%), but most were isolated prolonged CEPI closure times predominantly due to aspirin therapy (79 patients). Prolonged CADP closure times were most frequently due to qualitative platelet defects and/or decreased vWF levels. Prolonged CADP closure times were encountered most frequently in patients with sickle cell disease and were associated with a decreased hematocrit. This study demonstrated that the PFA-100 analyzer can accurately assess vWF-dependent platelet function and detect other platelet defects under high shear stress in complex patient populations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10928477

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  Women with red hair report a slightly increased rate of bruising but have normal coagulation tests.

Authors:  Edwin B Liem; Sandra C Hollensead; Teresa V Joiner; Daniel I Sessler
Journal:  Anesth Analg       Date:  2006-01       Impact factor: 5.108

2.  Inconsistency of different methods for assessing ex vivo platelet function: relevance for the detection of aspirin resistance.

Authors:  Giulia Renda; Maria Zurro; Gelsomina Malatesta; Benedetta Ruggieri; Raffaele De Caterina
Journal:  Haematologica       Date:  2010-12       Impact factor: 9.941

3.  Time-dependent changes in non-COX-1-dependent platelet function with daily aspirin therapy.

Authors:  Deepak Voora; Thomas L Ortel; Joseph E Lucas; Jen-Tsan Chi; Richard C Becker; Geoffrey S Ginsburg
Journal:  J Thromb Thrombolysis       Date:  2012-04       Impact factor: 2.300

4.  Preclinical Development of a vWF Aptamer to Limit Thrombosis and Engender Arterial Recanalization of Occluded Vessels.

Authors:  Shahid M Nimjee; David Dornbos; George A Pitoc; Debra G Wheeler; Juliana M Layzer; Nicholas Venetos; Allyson Huttinger; Spencer E Talentino; Nicholas J Musgrave; Holly Moody; Rachel E Rempel; Cheyenne Jones; Kendyl Carlisle; Jenna Wilson; Camille Bratton; Matthew E Joseph; Shoeb Khan; Maureane R Hoffman; Laura Sommerville; Richard C Becker; Jay L Zweier; Bruce A Sullenger
Journal:  Mol Ther       Date:  2019-03-30       Impact factor: 11.454

5.  Variables that Influence Platelet Function Analyzer-100™ Closure Times in Healthy Algerian Adults.

Authors:  Malika Belkacemi; Yassine Merad
Journal:  Int J Appl Basic Med Res       Date:  2021-07-19

6.  Platelet reactivity in response to aspirin and ticagrelor in African-Americans and European-Americans.

Authors:  Margaret Infeld; Kevin A Friede; Tan Ru San; Holly J Knickerbocker; Geoffrey S Ginsburg; Thomas L Ortel; Deepak Voora
Journal:  J Thromb Thrombolysis       Date:  2020-11-06       Impact factor: 2.300

7.  Establishment of reference intervals for Platelet Function Analyzer -100 closure time in Algerian adults.

Authors:  Malika Belkacemi; Yassine Merad; Mohamed Amine Merbouh
Journal:  PLoS One       Date:  2021-04-12       Impact factor: 3.240

8.  Harmonizing platelet function analyzer testing and reporting in a large laboratory network.

Authors:  Emmanuel J Favaloro; Soma Mohammed; Ronny Vong; Kent Chapman; Geoffrey Kershaw; Sarah Just; Lynne Connelly; Michael Ryan; Diane Zebeljan; Timothy Brighton; Leonardo Pasalic
Journal:  Int J Lab Hematol       Date:  2022-06-26       Impact factor: 3.450

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.